12/22
07:54 am
insm
Columbia Select Large Cap Growth Fund Q3 2025 Commentary [Seeking Alpha]
Low
Report
Columbia Select Large Cap Growth Fund Q3 2025 Commentary [Seeking Alpha]
12/20
07:27 am
insm
Insmed (NASDAQ:INSM) was upgraded by analysts at Truist Financial Corporation to a "strong-buy" rating.
Low
Report
Insmed (NASDAQ:INSM) was upgraded by analysts at Truist Financial Corporation to a "strong-buy" rating.
12/19
06:08 am
insm
Insmed (NASDAQ:INSM) was given a new $202.00 price target on by analysts at Truist Financial Corporation.
Medium
Report
Insmed (NASDAQ:INSM) was given a new $202.00 price target on by analysts at Truist Financial Corporation.
12/18
07:02 pm
insm
INSM Stock Plummets on Sinus Study Failure, Adds New Pipeline Asset [Yahoo! Finance]
Medium
Report
INSM Stock Plummets on Sinus Study Failure, Adds New Pipeline Asset [Yahoo! Finance]
12/18
05:52 pm
insm
Mizuho's Jared Holz talks Insmed sinking double digits on sinus drug trial news [CNBC]
Medium
Report
Mizuho's Jared Holz talks Insmed sinking double digits on sinus drug trial news [CNBC]
12/18
12:59 pm
insm
Insmed (NASDAQ:INSM) had its price target lowered by analysts at TD Cowen from $269.00 to $241.00. They now have a "buy" rating on the stock.
Low
Report
Insmed (NASDAQ:INSM) had its price target lowered by analysts at TD Cowen from $269.00 to $241.00. They now have a "buy" rating on the stock.
12/18
11:58 am
insm
Insmed's Pipeline Can Deliver Potential Gains Despite Brensocatib Setback, RBC Says [Yahoo! Finance]
Low
Report
Insmed's Pipeline Can Deliver Potential Gains Despite Brensocatib Setback, RBC Says [Yahoo! Finance]
12/18
11:24 am
insm
Insmed's ‘win streak' ends as top drug fails study in chronic nasal condition [Yahoo! Finance]
Low
Report
Insmed's ‘win streak' ends as top drug fails study in chronic nasal condition [Yahoo! Finance]
12/18
11:03 am
insm
Insmed (NASDAQ:INSM) was given a new $230.00 price target on by analysts at HC Wainwright.
Low
Report
Insmed (NASDAQ:INSM) was given a new $230.00 price target on by analysts at HC Wainwright.
12/18
10:58 am
insm
Insmed (NASDAQ:INSM) was given a new $212.00 price target on by analysts at Mizuho.
Low
Report
Insmed (NASDAQ:INSM) was given a new $212.00 price target on by analysts at Mizuho.
12/18
10:58 am
insm
Insmed (NASDAQ:INSM) was given a new $241.00 price target on by analysts at Cowen Inc.
Low
Report
Insmed (NASDAQ:INSM) was given a new $241.00 price target on by analysts at Cowen Inc.
12/18
10:04 am
insm
Insmed (NASDAQ:INSM) was given a new $203.00 price target on by analysts at Wedbush.
Low
Report
Insmed (NASDAQ:INSM) was given a new $203.00 price target on by analysts at Wedbush.
12/18
08:43 am
insm
Insmed (NASDAQ:INSM) had its price target lowered by analysts at Guggenheim from $230.00 to $221.00. They now have a "buy" rating on the stock.
Low
Report
Insmed (NASDAQ:INSM) had its price target lowered by analysts at Guggenheim from $230.00 to $221.00. They now have a "buy" rating on the stock.
12/18
08:03 am
insm
Insmed (NASDAQ:INSM) was given a new $195.00 price target on by analysts at Wells Fargo & Company.
Low
Report
Insmed (NASDAQ:INSM) was given a new $195.00 price target on by analysts at Wells Fargo & Company.
12/18
07:23 am
insm
These Stocks Are Moving the Most Today: Micron, Sandisk, DJT, Lululemon, Insmed, Coinbase, Rivian, CarMax, and More [Yahoo! Finance]
Low
Report
These Stocks Are Moving the Most Today: Micron, Sandisk, DJT, Lululemon, Insmed, Coinbase, Rivian, CarMax, and More [Yahoo! Finance]
12/18
07:11 am
insm
Insmed (NASDAQ:INSM) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Insmed (NASDAQ:INSM) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
12/18
07:11 am
insm
Insmed (NASDAQ:INSM) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Medium
Report
Insmed (NASDAQ:INSM) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
12/18
07:10 am
insm
Insmed (NASDAQ:INSM) was given a new $167.00 price target on by analysts at Wolfe Research. They now have an "outperform" rating on the stock.
Medium
Report
Insmed (NASDAQ:INSM) was given a new $167.00 price target on by analysts at Wolfe Research. They now have an "outperform" rating on the stock.
12/18
06:12 am
insm
Micron, Sandisk, Lululemon, Insmed, Rivian, PayPal, and More Stock Market Movers [Barron's]
Medium
Report
Micron, Sandisk, Lululemon, Insmed, Rivian, PayPal, and More Stock Market Movers [Barron's]
12/18
06:08 am
insm
Insmed (NASDAQ:INSM) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Medium
Report
Insmed (NASDAQ:INSM) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
12/17
04:01 pm
insm
Insmed Provides Clinical and Business Update
High
Report
Insmed Provides Clinical and Business Update
12/17
04:34 am
insm
Insmed Impresses With Pulmonary Portfolio, But Still Lacks Remedy To Turn A Profit [Seeking Alpha]
Low
Report
Insmed Impresses With Pulmonary Portfolio, But Still Lacks Remedy To Turn A Profit [Seeking Alpha]
12/16
08:04 am
insm
Insmed (NASDAQ:INSM) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
Insmed (NASDAQ:INSM) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
12/16
07:09 am
insm
Insmed (NASDAQ:INSM) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Low
Report
Insmed (NASDAQ:INSM) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
12/15
02:05 pm
insm
Hot Picks: Biotech stocks to watch as new drugs near market [BNN Bloomberg (Canada)]
Low
Report
Hot Picks: Biotech stocks to watch as new drugs near market [BNN Bloomberg (Canada)]